Sucrose-Containing IGIV May Pose Greater Risk Of Acute Renal Failure - FDA
Executive Summary
Immune globulin intravenous products containing sucrose may be associated with a greater risk of acute renal failure, FDA's Center for Biologics Evaluation & Research Office of Blood Research & Review said in a Nov. 13 letter to physicians.